Simmons Jeffrey N 4

What Happened
Jeffrey N. Simmons, President, CEO and Director of Elanco Animal Health Inc. (ELAN), received a grant of 117.887 deferred stock units on 2026-03-20. The units were recorded at $23.98 each, totaling about $2,827. The transaction is coded as an award/grant (A) and is a derivative award rather than an open-market purchase.

Key Details

• Transaction date: 2026-03-20; filing date: 2026-03-24 (filed within the two-business-day Form 4 window).
• Price reported: $23.98 per unit; total reported value: ~$2,827.
• Security type: Deferred stock units (derivative). Transaction code: A (award/grant).
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes: F1—each deferred stock unit equals the right to one share or the cash equivalent; F2—units settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.

Context
Deferred stock units are a form of executive compensation that convert to shares or cash at a later date and do not reflect an immediate market purchase or sale. This grant is routine compensation-related activity (modest in dollar value) and should be interpreted differently than open-market buys or sales.